Yes, combining two glucose-lowering agents increases hypoglycemia risk, particularly if you also take diabetes medications like metformin
The Medicare Part D coverage change that affects 67 million people On January 1, 2026, Medicare Part D began covering GLP-1 medications for obesity treatment under the Treat and Reduce Obesity Act provisions
These effects are linked to how GLP-1s can affect regions of the brain associated with reward-seeking and pleasure
External resources PMC - Alternative dosing regimens of GLP-1 receptor agonists PMC - Clinical recommendations for GI adverse events with GLP-1 agonists For researchers serious about optimizing their GLP-1 protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, dosing calculators, protocol databases, and a community of thousands who have navigated these exact questions about dosing optimization and side effect management
We often advise clients to reduce intake of high-fat and highly processed foods while on semaglutide
Once you reach your goal, we'll help you create a maintenance plan to prevent weight gain